Altaire Recalls Equate Eye Ointment Due to Sterility Concerns
Altaire Pharmaceuticals is recalling Equate Restore PM Nighttime Lubricant Eye Ointment because the product may not be sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an ophthalmic product, which poses a significant risk of infection and potential serious injury.
Plain-English summary
Altaire Pharmaceuticals, Inc. is recalling Equate Restore PM Nighttime Lubricant Eye Ointment, Sterile, Net Wt. 0.125 oz. (3.5g). The recall is being conducted due to a lack of assurance of sterility. The product is distributed by Walmart Stores Inc. and is identified by NDC 49035-191-50.
The recall covers 1,537,130 units distributed nationwide in the U.S.A. Affected lots include SKG, SHK, SHJ, SEC, SCB, SBC, RLB, RBB, RHR, RFK, RAB, TAD, TAQ, TBI, TDB, QHE, QJD, and SGE, with expiration dates ranging from 01/20 to 04/22.
Consumers should stop using the product and return it to the place of purchase for a refund. The FDA has classified this recall as Class II, indicating that use of or exposure to the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Equate Restore PM Nighttime Lubricant Eye Ointment, Sterile, Net Wt. 0.125 oz. (3.5g), Distributed by: Walmart Stores Inc., Bentonville, AR 72716, W-M item #551282425, NDC 49035-191-50
- Manufacturer
- Altaire Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Affected units
- 1,537,130
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: SKG
- Exp 08/21
- SHK
- Exp 08/21
- SHJ
- SEC
- Exp 05/21
- SCB
- Exp 03/21
- SBC
- Exp 02/21
- RLB
- Exp 12/20
- RBB
- Exp 02/20
- RHR
- Exp 08/20
- RFK
- Exp 06/20
- RAB
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 134 products in this recall →Related recalls
Same manufacturer · Altaire Pharmaceuticals, Inc.
See all →- SevereCVS Health Dry Eye Relief Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls Equate Support Advanced Twin Pack Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls OCuSOFT Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighEquate Lubricant Eye Ointment Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2024-03-06
- HighEquate Stye Lubricant Eye Ointment recalled due to sterility assurance failure
FDA (Drugs) · 2024-03-06
- HighFDA Recalls Eye Ointment Product Due to Sterility Assurance Failure
FDA (Drugs) · 2023-09-27
- CriticalFDA recalls non-sterile EQUATE lubricant eye drops nationwide
FDA (Drugs) · 2024-02-14
- HighFDA Recalls Refresh P.M. Eye Ointment Due to Potential Sterility Breach
FDA (Drugs) · 2024-10-02
- SevereSystane Lubricant Eye Gel Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-05-06